Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

被引：0
|
作者：
Hojjat-Farsangi, Mohammad [1 ]
Mozaffari, Fariba [1 ]
Daneshmanesh, Amir Hossein [1 ]
Osterborg, Anders [2 ]
Shokri, Faze [3 ]
Mellstedt, Hakan [4 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden
[3] Univ Tehran Med Sci, Dept Immunol, Sch Publ Hlth, Tehran, Iran
[4] Karolinska Inst, Karolinska Univ Hosp, Dept Oncol Radiumhemmet & Hematol, Canc Ctr Karolinska, Stockholm, Sweden
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：773 / 773
页数：1
相关论文
共 50 条
  • [31] Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
    Heliste, Juho
    Jokilammi, Anne
    Paatero, Ilkka
    Chakroborty, Deepankar
    Stark, Christoffer
    Savunen, Timo
    Laaksonen, Maria
    Elenius, Klaus
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [32] Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo
    Liu, Zhuojun
    Liu, Jia
    Zhang, Tianming
    Shi, Mingxia
    Chen, Xiaofang
    Chen, Yun
    Yu, Jian
    PHARMACOLOGICAL RESEARCH, 2020, 151
  • [33] Combined ROR1 and CD160 Detection For Improved Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia (CLL)
    Farren, Timothy W.
    Liu, Fengting
    Macey, Marion G.
    Kipps, Thomas J.
    Warner, Noel
    Agrawal, Samir G.
    BLOOD, 2013, 122 (21)
  • [34] The Importance of Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia
    Ozturk, Hacer Berna Afacan
    Albayrak, Murat
    Yildiz, Abdulkerim
    Maral, Senem
    Akyol, Pinar
    Aras, Merih Reis
    Falay, Mesude
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (04): : 199 - 204
  • [35] B chronic lymphocytic leukemia cells express the orphan receptor tyrosine kinase ROR-1
    Manesh, A. H. Danesh
    Mikaelsson, E.
    Jeddi-Tehrani, M.
    Bayat, A. A.
    Ghods, R.
    Ostadkarampour, M.
    Akhondi, M.
    Lagercrantz, S.
    Larsson, C.
    Osterborg, A.
    Shokri, F.
    Mellstedt, H.
    Rabbani, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 190 - 191
  • [36] Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)
    Jeong, Soo Young
    Lee, Kyung-jun
    Cha, Jieum
    Park, So Yoon
    Kim, Hyeong Su
    Kim, Jung Han
    Lee, Jae-Jun
    Kim, Namhyeok
    Park, Sung Taek
    MEDICINA-LITHUANIA, 2022, 58 (12):
  • [37] Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment
    Luo, Dongdong
    Qiu, Xingyang
    Zheng, Qingquan
    Ming, Yue
    Pu, Wencheng
    Ai, Ming
    He, Jianhua
    Peng, Yong
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (13) : 10655 - 10686
  • [38] ROR1 Negative Chronic Lymphocytic Leukemia (CLL) Have a Distinctive Gene Expression Signature and May Represent an Indolent-Disease Subtype
    Ghia, Emanuela M.
    Rassenti, Laura Z.
    Chen, Liguang
    Cui, Bing
    Deboever, Christopher
    Frazer, Kelly A.
    Kipps, Thomas J.
    BLOOD, 2015, 126 (23)
  • [39] Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies
    Dave, Hema
    Anver, Miriam R.
    Butcher, Donna O.
    Brown, Patrick
    Khan, Javed
    Wayne, Alan S.
    Baskar, Sivasubramanian
    Rader, Christoph
    PLOS ONE, 2012, 7 (12):
  • [40] Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma
    Khaledian, Behnoush
    Taguchi, Ayumu
    Shin-ya, Kazuo
    Kondo-Ida, Lisa
    Kagaya, Noritaka
    Suzuki, Motoshi
    Kajino, Taisuke
    Yamaguchi, Tomoya
    Shimada, Yukako
    Takahashi, Takashi
    CANCER SCIENCE, 2021, 112 (03) : 1225 - 1234
12345